21 December 2016
The report goes on to say
Bethesda-based GTI Maryland contends that the Maryland Medical Cannabis Commission broke its own rules last month when it granted preliminary licenses to two companies that were ranked lower by analysts who were charged with assessing the applicants.
The commission said it was trying to achieve more geographic diversity, as required by law.
GTI, one of two higher-ranking companies not selected, argues the commission’s decision-making process was “illogical, opaque and fatally flawed.” The company is asking the court to issue an injunction reversing it.
“This is a case about a state commission setting rules and then inexplicably failing to follow them,” said Philip M. Andrews, a Baltimore lawyer who represents GTI.
GTI filed the lawsuit in Baltimore Circuit Court on Monday.